Matthew Sherwood MD, MHS, FSCAI , Keith B. Allen MD , Thom G. Dahle MD, FSCAI , Chandan M. Devireddy MD, FSCAI , Jeffrey Gaca MD , Santiago Garcia MD, FSCAI , Kendra J. Grubb MD, MHA , Tsuyoshi Kaneko MD , Chad A. Kliger MD, FSCAI , Robert J. Lederman MD , John C. Messenger MD, FSCAI , Puja B. Parikh MD, MPH, FSCAI , Marie-France Poulin MD, FSCAI , Carlos Sanchez MD, FSCAI , Anene Ukaigwe MD, FSCAI , James J. Yun MD , Paul D. Mahoney MD, FSCAI
{"title":"SCAI Expert Consensus Statement on Alternative Access for Transcatheter Aortic Valve Replacement","authors":"Matthew Sherwood MD, MHS, FSCAI , Keith B. Allen MD , Thom G. Dahle MD, FSCAI , Chandan M. Devireddy MD, FSCAI , Jeffrey Gaca MD , Santiago Garcia MD, FSCAI , Kendra J. Grubb MD, MHA , Tsuyoshi Kaneko MD , Chad A. Kliger MD, FSCAI , Robert J. Lederman MD , John C. Messenger MD, FSCAI , Puja B. Parikh MD, MPH, FSCAI , Marie-France Poulin MD, FSCAI , Carlos Sanchez MD, FSCAI , Anene Ukaigwe MD, FSCAI , James J. Yun MD , Paul D. Mahoney MD, FSCAI","doi":"10.1016/j.jscai.2024.102514","DOIUrl":null,"url":null,"abstract":"<div><div>Transcatheter aortic valve replacement (TAVR) has become a widely accepted procedure for treating patients with symptomatic aortic stenosis. While transfemoral access remains the primary route due to its lower complication rates and favorable outcomes, a subset of patients have anatomical or clinical factors precluding this approach. For these patients, alternative access routes such as transaxillary, transcarotid, and transcaval provide viable options. This expert consensus statement aims to provide a comprehensive review of case selection, technical considerations, and outcomes associated with these alternative access routes in TAVR. Additionally, this document highlights the advancements in device technology and imaging guidance that have contributed to improving the safety and efficacy of alternative access TAVR. This consensus statement serves as a practical guide on best practices for interventional cardiologists, cardiothoracic surgeons, and heart teams in selecting patients and performing alternative access TAVR.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 3","pages":"Article 102514"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Society for Cardiovascular Angiography & Interventions","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772930324022038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Transcatheter aortic valve replacement (TAVR) has become a widely accepted procedure for treating patients with symptomatic aortic stenosis. While transfemoral access remains the primary route due to its lower complication rates and favorable outcomes, a subset of patients have anatomical or clinical factors precluding this approach. For these patients, alternative access routes such as transaxillary, transcarotid, and transcaval provide viable options. This expert consensus statement aims to provide a comprehensive review of case selection, technical considerations, and outcomes associated with these alternative access routes in TAVR. Additionally, this document highlights the advancements in device technology and imaging guidance that have contributed to improving the safety and efficacy of alternative access TAVR. This consensus statement serves as a practical guide on best practices for interventional cardiologists, cardiothoracic surgeons, and heart teams in selecting patients and performing alternative access TAVR.